Sort
23,748 grants matching “melanoma”
Multivalent Small Circular mRNA Vaccines for Melanoma Combination Immunotherapy
$563,293Guizhi Zhu · University Of Michigan At Ann Arbor · R01 · FY2025 · CA
The rodent eye as a non-invasive window for understanding cancer nanotherapeutics
$563,282Kit S Lam · University Of California At Davis · U01 · FY2019 · CA
Targeting S1P-ACC Axis to Overcome MDSC Suppression
$563,233Shikhar Mehrotra · Medical University Of South Carolina · R01 · FY2025 · CA
Dissecting the immunomodulatory effects of NK cells on immune responses to cancer
$563,228Kevin C Barry · Fred Hutchinson Cancer Center · R01 · FY2025 · CA
The KIT Signaling Pathway as a Therapeutic Target in Melanoma
$563,224Boris C Bastian · Wistar Institute · P01 · FY2012 · CA
Flow Cytometry
$563,202Michael W Andreeff · University Of Tx Md Anderson Can Ctr · P30 · FY2010 · CA
ALTERED MICRORNAS IN MELANOMA BRAIN METASTASIS
$562,943New York University · · FY2010 · Department of the Army
Near-Infrared Fluorescence Nanoparticles for Targeted Optical Imaging
$562,915Chun Li · University Of Tx Md Anderson Can Ctr · R01 · FY2008 · CA
Project 3: Tools for Capturing Immune Cell/Cancer Cell Interactions in Cancer Immunotherapies and Combination Immunotherapies
$562,890James R. Heath · Institute For Systems Biology · U54 · FY2017 · CA
IL-1 HOMOLOGUES PROMOTE THE ACUTE INFLAMMATORY RESPONSE TO MELANOMA
$562,884Michael T Lotze · University Of Pittsburgh At Pittsburgh · P01 · FY2007 · CA
Integrated Discovery Pipeline for Tumor Neoantigens
$562,825Beatriz M. Carreno · University Of Pennsylvania · R01 · FY2016 · CA
Molecular Basis for Transmembrane Conduction & Signaling
$562,812Robert M Stroud · University Of California, San Francisco · R01 · FY2023 · GM
Molecular Basis for Transmembrane Conduction & Signaling
$562,812Robert M Stroud · University Of California, San Francisco · R01 · FY2024 · GM
Molecular Basis for Transmembrane Conduction & Signaling
$562,812Robert M Stroud · University Of California, San Francisco · R01 · FY2022 · GM
Defining mechanisms to promote antitumor immunity by modulating one-carbon metabolism
$562,761Arlene H Sharpe · Harvard Medical School · R01 · FY2025 · CA
Multimeric Ligands for Targeting of Melanoma
$562,725University Of Arizona · R01 · FY2003 · CA
RNA editing in islet function and inflammation
$562,668Alvin Carter Powers · Vanderbilt University Medical Center · R01 · FY2023 · DK
Nucleus Accumbens-Associated Protein-1 in Melanoma Immunotherapy
$562,597Jin-Ming Yang · University Of Kentucky · R01 · FY2020 · CA
Modeling Tyrosine Kinase Inhibitor-Induced Vascular Dysfunction Using Human iPSCs
$562,562Joseph C Wu · Stanford University · R01 · FY2021 · HL
PROCESSED ANTIGEN CHARACTERIZATION BY MASS SPECTROMETRY
$562,412University Of Virginia Charlottesville · R37 · FY2003 · AI
Mechanism of Activity of Lonidamine
$562,245Jerry D Glickson · University Of Pennsylvania · R01 · FY2015 · CA
Elucidation of Human Natural Killer Cell Development
$562,208Aharon G Freud · Ohio State University · R01 · FY2025 · CA
Communication Intervention with Melanoma Families
$562,073Deborah J. Bowen · Fred Hutchinson Cancer Research Center · R01 · FY2007 · CA
Identification of Melanoma Susceptibility Gene at 1p22
$562,030Translational Genomics Research Inst · R01 · FY2005 · CA
Lymphatic Mapping and Sentinel Node ANALYSIS
$561,952John Wayne Cancer Institute · R01 · FY2004 · CA